Hyperglycemia-induced suppression of IGF-binding protein synthesis and the promotion of IGF-1 synthesis increase the amounts of bioavailable IGF-1 in circulation; an established critical risk factor for several malignancies (Pollak, 2008). This evidence concerns the gene IGF1 and Hyperglycemia.